| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |